H. Lundbeck A/S (HLBBF)
OTCMKTS
· Delayed Price · Currency is USD
5.65
-0.45 (-7.38%)
At close: Dec 17, 2024
H. Lundbeck Revenue
H. Lundbeck had revenue of 5.72B DKK in the quarter ending September 30, 2024, with 15.55% growth. This brings the company's revenue in the last twelve months to 21.44B, up 9.31% year-over-year. In the year 2023, H. Lundbeck had annual revenue of 19.91B with 9.13% growth.
Revenue (ttm)
21.44B DKK
Revenue Growth
+9.31%
P/S Ratio
n/a
Revenue / Employee
3.77M DKK
Employees
5,681
Market Cap
5.38B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
Dec 31, 2019 | 17.04B | -1.08B | -5.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
H. Lundbeck News
- 6 weeks ago - Longboard Pharmaceuticals HSR waiting period expires for Lundbeck deal - Seeking Alpha
- 2 months ago - Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management - Seeking Alpha
- 2 months ago - NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday - Benzinga
- 2 months ago - Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record - Investor's Business Daily
- 2 months ago - Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MarketWatch
- 2 months ago - Lundbeck to Acquire Longboard Pharmaceuticals (LBPH) for $2.6 Billion - GuruFocus
- 2 months ago - Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? - Benzinga
- 2 months ago - Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket - Benzinga